Alphabet Faces Dual Setbacks as Pharma Partnership Dissolves and EU Launches Fresh Probe

Alphabet Inc., the parent company of Google, encountered significant headwinds on Thursday as two separate challenges emerged simultaneously. The technology conglomerate saw the collapse of a multi-billion dollar pharmaceutical collaboration while European regulators initiated a new investigation into its business practices, creating a perfect storm of negative developments.

The European Commission has turned its regulatory attention to Google’s treatment of news publishers within its search results. The investigation will examine whether the tech giant systematically disadvantages publishers who incorporate sponsored content or commercial third-party articles in their offerings.

This probe falls under the jurisdiction of the Digital Markets Act (DMA), one of Brussels’ most stringent regulatory Read more...